Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2011 May;193(9):2168–2176. doi: 10.1128/JB.01449-10

Absence of PmrAB-Mediated Phosphoethanolamine Modifications of Citrobacter rodentium Lipopolysaccharide Affects Outer Membrane Integrity,

Charles Viau 1, Valerie Le Sage 1, Daniel K Ting 1, Jeremy Gross 1, Hervé Le Moual 1,2,*
PMCID: PMC3133075  PMID: 21378194

Abstract

The PmrAB two-component system of enterobacteria regulates a number of genes whose protein products modify lipopolysaccharide (LPS). The LPS is modified during transport to the bacterial outer membrane (OM). A subset of PmrAB-mediated LPS modifications consists of the addition of phosphoethanolamine (pEtN) to lipid A by PmrC and to the core by CptA. In Salmonella enterica, pEtN modifications have been associated with resistance to polymyxin B and to excess iron. To investigate putative functions of pEtN modifications in Citrobacter rodentium, ΔpmrAB, ΔpmrC, ΔcptA, and ΔpmrC ΔcptA deletion mutants were constructed. Compared to the wild type, most mutant strains were found to be more susceptible to antibiotics that must diffuse across the LPS layer of the OM. All mutant strains also showed increased influx rates of ethidium dye across their OM, suggesting that PmrAB-regulated pEtN modifications affect OM permeability. This was confirmed by increased partitioning of the fluorescent dye 1-N-phenylnaphthylamine (NPN) into the OM phospholipid layer of the mutant strains. In addition, substantial release of periplasmic β-lactamase was observed for the ΔpmrAB and ΔpmrC ΔcptA strains, indicating a loss of OM integrity. This study attributes a new role for PmrAB-mediated pEtN LPS modifications in the maintenance of C. rodentium OM integrity.

INTRODUCTION

The outer membrane (OM) of Gram-negative bacteria is asymmetric, with lipopolysaccharide (LPS) forming the outer leaflet (26). The LPS layer functions as a permeability barrier to antibacterial compounds, including lipophilic antibiotics and host antimicrobial peptides (AMPs). Lipophilic antibiotics must cross the OM by diffusion through the LPS layer. AMPs are typically too large to diffuse through porin channels (molecular mass cutoff, <600 Da); they penetrate the OM by perturbing the lateral interactions between neighboring LPS molecules mediated by divalent Mg2+ and Ca2+ cations. Limiting concentrations of these cations undermine the OM permeability barrier to the action of AMPs and lipophilic antibiotics (7). Enterobacteria have developed an adaptive response for remodeling the OM by modifying LPS. In response to various environmental signals, the PhoPQ and PmrAB two-component systems (TCS) control these LPS modifications at the transcriptional level (11, 15, 17). LPS modifications decrease OM permeability by adding palmitate to lipid A (encoded by the pagP gene) (29). They also neutralize negative charges of LPS by adding 4-aminoarabinose (encoded by the arn operon) or phosphoethanolamine (pEtN) (encoded by the pmrC and cptA genes) to specific phosphate groups (12, 29). Early studies have highlighted an association between PmrAB-mediated modifications of LPS and increased resistance of Salmonella enterica to the AMP polymyxin B (PMB) (36, 37). Later studies showed that PmrAB-mediated LPS modifications also have a role in the survival of S. enterica exposed to excess iron (5, 41). In S. enterica, the PhoPQ TCS controls the PmrAB TCS and the RcsBCD phosphorelay system (3, 10). PhoPQ controls PmrAB signaling by promoting expression of the PmrD protein, which binds the response regulator PmrA and prevents its dephosphorylation, resulting in sustained activation of PmrA-regulated genes (18, 20).

The extracellular enteric pathogen Citrobacter rodentium causes transmissible colonic hyperplasia in mice (32). C. rodentium has virulence factors similar to those of enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic Escherichia coli (EHEC), making it an excellent model organism for the study of these human pathogens. Sequencing of the C. rodentium genome revealed striking differences from that of S. enterica (28). For example, C. rodentium does not appear to have the pmrD gene, suggesting that PhoPQ does not control PmrA-regulated genes, as observed previously in Yersinia pestis (40). In addition, the PmrA-regulated arn operon (also known as the pmrHFIJKLM operon) is also absent from the C. rodentium genome. The arn operon is responsible for the addition of 4-aminoarabinose to lipid A, a modification that is central to PMB resistance (16). These observations are consistent with the fact that a C. rodentium ΔphoPQ strain does not have greater susceptibility to PMB than the wild type (21). Among the other LPS-modifying PmrA-regulated genes, C. rodentium possesses the pmrC and cptA homologues. The pmrC and cptA genes encode pEtN transferases responsible for mediating the addition of pEtN to the 1 and 4′ phosphates of lipid A and to the phosphate of heptose I found in the LPS core, respectively (12, 29). Addition of pEtN to lipid A or the LPS core has been shown to have a modest effect on PMB resistance (13, 14, 34). Recently, it was shown that the single pEtN transferase of Campylobacter jejuni adds pEtN to both lipid A and the flagellar rod protein FlgG, affecting bacterial motility (6). This study indicated that pEtN modifications may have other roles.

C. rodentium does not have the ability to modify LPS with 4-aminoarabinose, which interferes with the addition of pEtN to the 4′ phosphate of lipid A in S. enterica (43). Therefore, C. rodentium is an organism of choice for studying the biological function of pEtN modifications. In this study, the objective was to characterize C. rodentium pmrAB, pmrC, and cptA deletion mutants. We found that the absence of PmrAB-mediated pEtN modifications of LPS increases OM permeability to lipophilic compounds and affects OM integrity, highlighting a new role for pEtN modifications.

MATERIALS AND METHODS

Media and reagents.

Bacteria were grown at 37°C with aeration in Luria-Bertani (LB) broth, Trypticase soy broth (TSB), or N-minimal medium (pH 7.5) containing 0.2% glucose (21) and supplemented with MgCl2 and FeSO4, as needed. When appropriate, media were supplemented with chloramphenicol (30 μg/ml) or kanamycin (50 μg/ml). Polymyxin B (PMB), cephalothin, norfloxacin, erythromycin, novobiocin, vancomycin, ethidium bromide (EtBr), 1-N-phenylnaphthylamine (NPN), and carbonyl cyanide meta-chlorophenylhydrazone (CCCP) were purchased from Sigma. Nitrocefin was from EMD Chemicals. Restriction enzymes and Pfx DNA polymerase were from New England BioLabs and Invitrogen, respectively.

Construction of C. rodentium deletion mutants.

The bacterial strains and plasmids used in this study are listed in Table 1. DNA purification, cloning, and transformation were performed according to standard procedures (31). The C. rodentium ΔpmrAB, ΔpmrC, ΔcptA, ΔpmrC ΔcptA, and ΔphoPQ ΔpmrAB deletion mutants were generated by sacB gene-based allelic exchange (8). The upstream and downstream sequences of the cptA, pmrC, and pmrAB genes were PCR amplified from C. rodentium genomic DNA using the primers listed in Table 2. PCR fragments were gel purified, digested with the appropriate restriction enzymes (Table 2), and ligated into pRE112 cleaved with XbaI and SacI. Resulting plasmids were verified by sequencing, transformed into the E. coli χ7213 donor strain, and conjugated into the appropriate C. rodentium strain. Chromosomal plasmid insertion was selected for by culturing on LB agar supplemented with chloramphenicol. Selected clones were cultured on peptone agar containing 5% sucrose to isolate colonies that were sucrose resistant. These resulting colonies were also tested for chloramphenicol sensitivity. Gene deletions were verified by PCR. Plasmids used for complementation were constructed by PCR amplifying the genes of interest with their promoters from C. rodentium genomic DNA using the primers listed in Table 2 (for pmrAB, CR677 and CR680; for pmrC, CR694 and CR697; and for cptA, CR756 and CR757). The resulting PCR products were cloned into the XbaI and BamHI or XbaI and SacI restriction sites of plasmid pWSK129, generating plasmids pWSKpmrAB, pWSKpmrC, and pWSKcptA. In pWSKpmrAB, pmrAB was under the control of the constitutive promoter located at the 3′ end of the pmrC coding region (33).

Table 1.

Bacterial strains and plasmids used in this study

Strain, genotype, or plasmid Description Source or reference
C. rodentium strain or genotype
    DBS100 Wild-type C. rodentium strain (ATCC 51459) 32
    ΔphoPQ DBS100 ΔphoPQ 21
    ΔpmrAB DBS100 ΔpmrAB This study
    ΔpmrC DBS100 ΔpmrC This study
    ΔcptA DBS100 ΔcptA This study
    ΔpmrC ΔcptA DBS100 ΔpmrC ΔcptA This study
    ΔphoPQ ΔpmrAB DBS100 ΔphoPQ ΔpmrAB This study
    DBS100 pmrC::lacZ pmrC::lacZ in DBS100, Cmr This study
    ΔphoPQ pmrC::lacZ pmrC::lacZ in ΔphoPQ, Cmr This study
    ΔpmrAB pmrC::lacZ pmrC::lacZ in ΔpmrAB, Cmr This study
    DBS100 cptA::lacZ cptA::lacZ in DBS100, Cmr This study
    ΔphoPQ cptA::lacZ cptA::lacZ in ΔphoPQ, Cmr This study
    ΔpmrAB cptA::lacZ cptA::lacZ in ΔpmrAB, Cmr This study
E. coli strain
    χ7213 thr-1 leuB6 fhuA21 lacY1 glnV44 recA1 asdA4 thi-1 RP4-2-Tc::Mu [-pir] Kanr 30
Plasmids
    pRE112 Sucrose-sensitive (sacB1) suicide vector, Cmr 9
    pFUSE Suicide vector, lacZYA, mob+ (RP4), ori R6K, Cmr 2
    pWSK129 Low-copy-no. cloning vector, Kanr 38
    pWSKpmrAB This study
    pWSKpmrC This study
    pWSKcptA This study

Table 2.

Primers used in this study

Primer Sequencea Usage
CR677 AGCTAGTCTAGATGTTCTCCGGAATGCCACGCAAGC ΔpmrAB 5′F XbaI
CR678 AGCTAGGATATCGGTGTCGCGGGCGGTCAGGATCAG ΔpmrAB 5′R EcoRV
CR679 AGCTAGGATATCGCGGTGATGGGAGTTGAGGATCAG ΔpmrAB 3′F EcoRV
CR680 AGCTAGGAGCTCTTTCGCCGGTCTGCTGATGCTGGC ΔpmrAB 3′R SacI
CR694 GACTAGTCTAGACCAGCAGAATCAGGCCGATAG ΔpmrC 5′F XbaI
CR695 AGCCATGATATCACGGCGTAAATGCGGACTCG ΔpmrC 5′R EcoRV
CR696 AGCTAGGATATCCAGCGGCATCGACAGAAAGAC ΔpmrC 3′F EcoRV
CR697 CAGTGAGAGCTCCCGCTACATTCCAGAAGCCCT ΔpmrC 3′R SacI
CR719 TGACATCTAGAGGAGCTGGGCAAACTACCGCTC ΔcptA 5′F XbaI
CR734 TGCAGGTACCGCTAAATGCGGACGCGGGCTGG ΔcptA 5′R KpnI
CR735 GGTGGGTACCTGCGCTGATTGATTATGACACTCTG ΔcptA 3′F KpnI
CR722 GGCGGAGCTCTCAGGTCGTAGCCCTTCAGCAAC ΔcptA 3′R SacI
CR555 AGCTAGTCTAGAGATCTTAGCCCAGCTTTCGCAGTATCCGGTCTCC pmrC::lacZ 5′F XbaI
CR554 AGCTACCCCGGGAAACCAGCAGCAGCCAGGCGAGCAGTCTGAG pmrC::lacZ 3′R SmaI
CR774 AGCTAGTCTAGAATGCTGGAAATGGTCTTCGCCAAAG cptA::lacZ 5′F XbaI
CR775 AGCTACCCCGGGGCTAAATGCGGACGCGGGCTGG cptA::lacZ 3′R SmaI
CR756 GGTATCTACAGAAATGGTCTTCGCCAAAGCGGAT pWSKcptA 5′ XbaI
CR757 GCCAGAGCTCGATGTCCTCAAGTGATTATTGCCGG pWSKcptA 3′ SacI
a

Restriction sites are underlined.

Construction of chromosomal lacZ transcriptional fusions and β-galactosidase assay.

The pmrC or cptA promoter was PCR amplified using the primers listed in Table 2. The PCR fragments were digested with XbaI and SmaI and ligated upstream of the lacZ gene of the suicide vector pFUSE (2). The resulting constructs were transformed into E. coli χ7213, conjugated into the C. rodentium wild type, ΔphoPQ, and ΔpmrAB strains, and selected for by culturing on LB agar supplemented with chloramphenicol. Insertion of the suicide vector was verified by sequencing. β-Galactosidase activity assays were carried out in triplicate at least three times, as previously described (23).

MIC determination.

MICs were determined in 96-well microtiter plates using the broth microdilution method (39). Briefly, bacterial cultures were grown in TSB, diluted to 5 × 105 CFU/ml in N-minimal medium supplemented with 10 μM MgCl2 and 25 μM FeSO4 and aliquoted into rows of wells. Twofold serial dilutions of the tested antimicrobial compound were added to each row of wells. The plates were incubated at 37°C for 24 h. The lowest concentration of the antimicrobial compound that did not permit any visible growth was determined to be the MIC. Determination of MIC values was repeated at least three times until no variation was observed between replicates.

OM permeability assays.

N-minimal media supplemented with 1 mM MgCl2 were inoculated (1:80) with LB-grown overnight cultures of the various C. rodentium strains. Cultures were grown to an optical density at 600 nm (OD600) of 0.7 to 0.8. Cells were washed with phosphate-buffered saline (PBS) and resuspended in N-minimal medium supplemented with 10 μM MgCl2 and 25 μM FeSO4. At an OD600 of ≈1.3, cells were harvested by centrifugation and diluted in PBS to an OD600 of 0.4. The assay measuring ethidium influx rates was carried out as previously described (25). Briefly, cells (3 ml) were added to a quartz cuvette with stirring and incubated with 50 μM CCCP for 10 min to inactivate efflux pumps. EtBr was added to these bacterial suspensions at a final concentration of 4 μM. The fluorescence generated from the binding of ethidium to DNA was measured using a Varian Eclipse spectrofluorometer with excitation and emission wavelengths of 545 and 600 nm, respectively. Slit widths were 5 and 10 nm, respectively. The assay monitoring partitioning of NPN into membrane phospholipids was carried out as described elsewhere (22). NPN was added at a final concentration of 5 μM to bacteria resuspended in PBS (3 ml). Fluorescence generated by partitioning of NPN into phospholipids was measured as described above with an excitation wavelength of 350 nm, an emission wavelength of 420 nm, and slit widths set at 5 nm.

β-Lactamase leakage assay.

Bacterial cultures were grown as described under “OM permeability assays.” Release of the chromosomally encoded C. rodentium β-lactamase (ROD_12321; molecular mass, 32 kDa) from the periplasm to the supernatant was compared between the various C. rodentium strains to assess OM integrity. The chromogenic β-lactam nitrocefin was used as a substrate (27). In brief, the released β-lactamase fractions were isolated by collecting the supernatant of 1-ml culture aliquots. The periplasmic β-lactamase fractions were obtained by osmotic lysis of the remaining cells, using the protocol supplied with the Epicentre periplasmic protein extraction kit. Enzymatic assays were performed at 22°C in N-minimal medium, and β-lactamase activity was monitored by measuring the absorbance at 482 nm for 30 min using a Powerwave X340 microplate reader (Bio-Tek Instruments). Slopes of OD482 as a function of time were calculated to determine β-lactamase activities in both the released and periplasmic fractions (27). Percentages of β-lactamase released into the culture supernatants were calculated by determining the ratio of β-lactamase activity in the supernatant to total β-lactamase activity (released and periplasmic fractions). Each strain was assayed in triplicate in multiple experiments.

RESULTS

Transcription of C. rodentium pmrC and cptA is regulated by PmrAB independently of PhoPQ.

The PhoP-regulated pmrD gene that connects the S. enterica PhoPQ and PmrAB signaling pathways is absent from the C. rodentium genome (28). The C. rodentium pmrC and cptA promoters contain PmrA-binding sites found in the same context as those described for S. enterica (1, 35). To examine whether expression of C. rodentium pmrC and cptA is under the control of PmrAB, chromosomal β-galactosidase fusions with the pmrC and cptA genes were constructed in the wild-type, ΔphoPQ, and ΔpmrAB C. rodentium strains. The lacZ reporter strains were grown under PhoPQ- and PmrAB-inducing conditions (10 μM MgCl2 and 25 μM FeSO4). The β-galactosidase activities of the pmrC::lacZ reporter in the wild-type and ΔphoPQ strains were very similar (Fig. 1A). In contrast, expression from the pmrC::lacZ reporter was not observed in the ΔpmrAB strain, indicating that pmrC is regulated by PmrAB in C. rodentium. Similar results were obtained by using FeCl3 or mild acidic pH (pH 5.5) as the PmrAB-inducing condition (data not shown). Expression from the cptA::lacZ reporter fusion was marginally affected in the ΔphoPQ strain and decreased by 3-fold in the ΔpmrAB strain, indicating that C. rodentium cptA is at least partly regulated by PmrAB (Fig. 1B). The residual expression from the cptA promoter in the ΔpmrAB strain suggests that other transcriptional factors regulate cptA expression (Fig. 1B). Transcriptional regulation of C. rodentium pmrC and cptA by PmrAB was further validated by measuring the expression of both reporter fusions in the presence of increasing concentrations of FeSO4 (Fig. 1C and D). Altogether, these data confirm that PmrAB regulates expression of the C. rodentium pmrC and cptA genes, as reported previously for S. enterica (1, 35). They also indicate that expression of pmrC and cptA is independent of PhoPQ.

Fig. 1.

Fig. 1.

Expression of C. rodentium pmrC and cptA is regulated by PmrAB independently of PhoPQ. (A) Expression of pmrC is strictly regulated by PmrAB. (B) Expression of cptA is primarily regulated by PmrAB. (C and D) β-Galactosidase activity from the pmrC::lacZ (C) or cptA::lacZ (D) reporter strains in the presence of increasing concentrations of FeSO4. The various pmrC::lacZ or cptA::lacZ reporter strains were constructed as described in Materials and Methods. Strains were grown up to an OD600 of 0.4 in N-minimal medium containing 1 mM MgCl2, washed in PBS, and resuspended in N-minimal medium supplemented with 10 μM MgCl2 and FeSO4, as indicated. After an additional 90-min incubation at 37°C, β-galactosidase activities were assayed using the CHCl3-sodium dodecyl sulfate permeabilization procedure (23). Values are means ± standard deviations of data from three independent experiments.

pEtN modifications protect C. rodentium from iron toxicity.

PmrAB-regulated LPS modifications have been associated with resistance to excess iron in S. enterica (5, 41). The susceptibility of the C. rodentium wild-type, ΔpmrAB, ΔpmrC, ΔcptA, and ΔpmrC ΔcptA strains to FeSO4 was assessed by determining MIC values. As shown in Table 3, all mutant strains were more susceptible to excess iron than the wild type. Compared to the wild-type strain, the ΔcptA and ΔpmrC strains exhibited 2- and 4-fold-lower MIC values, respectively. The ΔpmrC ΔcptA and ΔpmrAB strains showed much higher susceptibility to iron, with 8- and 16-fold lower MIC values, respectively. Complementation of the mutant strains with the pWSK129-derived pWSKpmrAB, pWSKpmrC, and pWSKcptA plasmids restored resistance to iron above the wild-type level (Table 3). Essentially similar data were obtained with FeCl3 (data not shown). Altogether, the data indicate that pEtN transferases protect C. rodentium from excess iron and support previous observations in S. enterica (5, 41). Due to the higher susceptibility of the mutant strains to excess iron, all subsequent experiments were performed in N-minimal medium supplemented with 25 μM FeSO4, a concentration of iron that induces expression of both pmrC and cptA (Fig. 1C and D) without affecting growth or viability of the various strains as judged by OD600 measurements and survival assays (see Fig. S1 in the supplemental material).

Table 3.

MICs of FeSO4 for C. rodentium strains

Strain description MIC of FeSO4 (μM) in N-minimal mediuma
Wild type 1,600
ΔpmrAB 100
ΔpmrC 400
ΔcptA 800
ΔpmrC ΔcptA 200
ΔpmrAB-pWSKpmrAB >1,600
ΔpmrC-pWSKpmrC >1,600
ΔcptA-pWSKcptA >1,600
a

N-minimal medium was supplemented with 10 μM MgCl2.

pEtN modifications and PMB resistance.

The role of C. rodentium PmrC and CptA in PMB resistance was assessed by determining MIC values. In N-minimal medium, MIC values of 2 μg/ml were obtained for all tested strains (Table 4). These results indicate that neither PmrC nor CptA is involved in resistance to PMB, at least under these experimental conditions. The data also suggest that no additional PmrAB-regulated C. rodentium genes play a role in PMB resistance. In LB broth, 2-fold decreases in MIC values were obtained for the ΔpmrC, ΔpmrCΔ cptA, and ΔpmrAB strains (Table 4). These slight differences in MIC values are consistent with findings of previous studies in which the marginal involvement of S. enterica PmrAB-mediated pEtN modifications in PMB resistance was reported (14, 34).

Table 4.

MICs of PMB for C. rodentium strains

Strain description MIC (μg/ml) of PMB in:
N-minimal mediuma LBb
Wild type 2 0.4
ΔpmrAB 2 0.2
ΔpmrC 2 0.2
ΔcptA 2 0.4
ΔpmrC ΔcptA 2 0.2
ΔpmrAB-pWSKpmrAB 2 0.4
ΔpmrC-pWSKpmrC 2 0.4
ΔcptA-pWSKcptA 2 0.4
a

N-minimal medium was supplemented with 10 μM MgCl2 and 25 μM FeSO4.

b

LB was supplemented with 500 μM FeSO4.

pEtN modifications confer resistance to lipophilic antibiotics.

Since both PmrC and CptA alter the structure of the LPS layer, susceptibility to different types of antibiotics was examined. Small hydrophilic antibiotics are known to diffuse across porins, whereas lipophilic antibiotics must diffuse across the asymmetrical bilayer of the OM (7, 26). MIC values were determined for the lipophilic antibiotics novobiocin and erythromycin (Table 5). The wild-type and ΔcptA strains were equally susceptible to novobiocin, with MIC values of 16 μg/ml. The MIC for the ΔpmrC strain was decreased by 2-fold. In contrast, the MIC for the ΔpmrC ΔcptA strain showed an 8-fold decrease. Consistently, a 4-fold reduction in the MIC value was obtained for the ΔpmrAB strain. Complementation of the ΔpmrAB and ΔpmrC strains with pWSKpmrAB and pWSKpmrC, respectively, restored the MIC values to the wild-type level (16 μg/ml) or to a greater extent (32 μg/ml). Complementation of the ΔcptA strain with pWSKcptA did not have an observable effect on the MIC value. Interestingly, complementation of the ΔpmrC ΔcptA strain with pWSKcptA or pWSKpmrC increased the MIC values to 8 and 16 μg/ml, respectively. A similar trend was observed with erythromycin, with the fold changes being much higher. Erythromycin MIC values were decreased by 16- and 32-fold for the ΔpmrC and ΔpmrC ΔcptA strains, respectively. All complemented single mutant strains had their MIC values equal to the wild-type value. As for novobiocin, complementation of the ΔpmrC ΔcptA strain with pWSKpmrC more effectively restored resistance to erythromycin than when complemented with pWSKcptA (Table 5). Altogether, the data indicate that PmrC-mediated addition of pEtN to LPS may have a preponderant role compared to the CptA-mediated modification in restricting access of lipophilic drugs across the OM. In addition, the data strongly suggest that modifications introduced by both PmrC and CptA act together to reinforce the LPS permeability barrier.

Table 5.

MICs of lipophilic and hydrophilic antibiotics and SDS for C. rodentium strains

Strain description MIC (μg/ml) of:
Novobiocin Erythromycin Cephalothin Norfloxacin Vancomycin SDS
Wild type 16 1,024 32 0.008 4 62,500
ΔpmrAB 4 32 64 0.016 1 15,625
ΔpmrC 8 64 32 0.016 2 31,250
ΔcptA 16 1,024 32 0.008 4 62,500
ΔcptA ΔpmrC 2 32 64 0.008 1 15,625
ΔpmrAB-pWSKpmrAB 32 1,024 32 0.016 8 62,500
ΔpmrC-pWSKpmrC 32 1,024 32 0.016 4 62,500
ΔcptA-pWSKcptA 16 1,024 32 0.016 4 62,500
ΔcptA ΔpmrC-pWSKpmrC 16 1,024 32 0.016 4 62,500
ΔcptA ΔpmrC-pWSKcptA 8 128 32 0.016 2 31,250

MIC values were also determined for the hydrophilic antibiotics cephalothin and norfloxacin (24). For both antibiotics, MIC values for all strains were essentially similar and did not exhibit the susceptibility pattern observed for novobiocin and erythromycin (Table 5). Susceptibility to the hydrophilic antibiotic vancomycin, which is too large (molecular mass, 1,450 Da) to diffuse through porins, was also examined. Obtained MIC values reflected the pattern of susceptibility observed for novobiocin and erythromycin (Table 5). This pattern of susceptibility was also obtained for SDS, a detergent that is used to assess OM integrity (Table 5). These data further support the possibility that pEtN modifications introduced by both PmrC and CptA are involved in the control of OM permeability and/or integrity.

pEtN modifications influence OM permeability to hydrophobic dyes.

In S. enterica, the PhoPQ-mediated modifications of LPS have been shown to strengthen the OM permeability barrier (19, 25). To determine the respective contributions of C. rodentium PhoPQ and PmrAB in controlling OM permeability, we compared the influx of EtBr into the wild-type, ΔphoPQ, ΔpmrAB, and ΔphoPQ ΔpmrAB strains. In this assay, diffusion of ethidium across the OM was shown to be the rate-limiting step (25). Ethidium influx rates were increased by 1.6-fold for the ΔpmrAB and ΔphoPQ ΔpmrAB strains compared to those for the wild-type strain (Fig. 2A). In contrast, the influx rate for the ΔphoPQ strain was similar to that for the wild-type strain. These observations highlight the importance of the PmrAB TCS in regulating OM permeability in C. rodentium. They are also consistent with the fact that transcriptional regulation of target genes by PmrAB is independent of PhoPQ in C. rodentium (Fig. 1). To assess whether PmrC and CptA are involved in reinforcing the OM permeability barrier, influx of ethidium into the ΔpmrC, ΔcptA, and ΔpmrC ΔcptA strains was monitored (Fig. 2B). The ΔpmrC ΔcptA and ΔpmrAB mutants showed similar ethidium influx rates that were 1.5-fold higher than that of the wild-type strain. Influx rates for the ΔpmrC and ΔcptA strains were intermediate and consistently higher than that of the wild type. Ethidium influx rates for the complemented strains were either similar (ΔcptA-pWSKcptA) or slightly lower (ΔpmrC-pWSKpmrC and ΔpmrAB-pWSKpmrAB) than that of the wild-type strain (data not shown). These results indicate that both pEtN modifications are required for the strengthening of the OM barrier and support the possibility that PmrC and CptA act in concert in this process.

Fig. 2.

Fig. 2.

Ethidium influx into C. rodentium mutant strains. (A) Ethidium influx into the wild-type, ΔphoPQ, ΔpmrAB, and ΔphoPQ ΔpmrAB strains. (B) Ethidium influx into the wild-type, ΔpmrC, ΔcptA, ΔpmrC ΔcptA, and ΔpmrAB strains. Cells were grown as described in Materials and Methods. Cultures were diluted in PBS to an OD600 of 0.4, transferred to a quartz cuvette, and stirred for the length of the experiment. EtBr was added at 0.5 min, and the influx of ethidium was monitored over 3 min by measuring fluorescence emission at 600 nm. Ethidium influx rates were calculated from the linear portions of the curves (1 to 3.5 min). One representative experiment of three independent experiments is shown. AU, arbitrary units.

To further confirm these observations, the partitioning of the uncharged fluorescent probe NPN into the asymmetric bilayer of these strains was measured. Fluorescence of NPN is weak in aqueous environments but strong in the hydrophobic environment of disrupted membranes (22). For the ΔpmrC ΔcptA and ΔpmrAB strains, the maximum fluorescence intensities of NPN were approximately 3-fold higher than that of the wild-type strain (Fig. 3A). Fluorescence intensities for the ΔpmrC and ΔcptA strains were consistently higher than that of the wild type, with that of the ΔpmrC strain consistently higher than that of the ΔcptA strain (Fig. 3A). These results are in agreement with the ethidium influx assays (Fig. 2). To clarify the individual contributions of PmrC and CptA in reinforcing the OM barrier, the ΔpmrC ΔcptA strain was complemented with the pWSKpmrC or pWSKcptA plasmid and assayed for NPN partitioning (Fig. 3B). In both cases, accumulation of NPN fluorescence was reduced to intermediate levels and complementation with pWSKpmrC consistently resulted in a larger reduction of fluorescence intensity (2.2-fold) than complementation with pWSKcptA (1.8-fold). These results show that both pEtN transferases are required to reach the wild-type level of OM impermeability. They also suggest that PmrC contributes to a larger extent than CptA to the strengthening of the OM barrier.

Fig. 3.

Fig. 3.

Partitioning of NPN into the OM of C. rodentium strains. (A) Change in fluorescence due to the partitioning of NPN into the OM of the wild-type, ΔpmrC, ΔcptA, ΔpmrC ΔcptA, and ΔpmrAB strains. (B) Change in fluorescence due to the partitioning of NPN into the OM of the wild-type, ΔpmrC ΔcptA, ΔpmrC ΔcptA-pWSKpmrC, and ΔpmrC ΔcptA-pWSKcptA strains. Bacterial cultures were grown as described in Materials and Methods, diluted in PBS to an OD600 of 0.4, and transferred to a quartz cuvette with stirring. NPN was added at 0.5 min, and NPN partitioning was monitored by measuring fluorescence emission at 420 nm over 3 min. One representative experiment of three independent experiments is shown. AU, arbitrary units.

Lack of pEtN modifications affect OM integrity.

To determine whether the weakened OM barrier observed in the absence of pmrC and cptA is due to strict increased permeability or loss of integrity, release of the endogenous C. rodentium β-lactamase into culture supernatants was assessed using the chromogenic substrate nitrocefin (27). As shown in Fig. 4, minimal release of β-lactamase (2 to 3%) was obtained for the wild-type and ΔcptA strains. β-Lactamase release was slightly higher (6%) for the ΔpmrC strain, although this was statistically insignificant. More dramatic leakage of β-lactamase (∼22%) was measured for the ΔpmrC ΔcptA and ΔpmrAB strains, which represented a 10-fold increase compared to that for wild type. These results clearly show that the lack of PmrAB-regulated pEtN transferases affects C. rodentium OM integrity. Complementation of the ΔpmrC ΔcptA strain with pWSKpmrC or pWSKcptA restored OM integrity to levels close to that of the wild type. However, analysis of LPS and OM protein profiles revealed that all C. rodentium strains exhibited a full-length LPS capped with O-polysaccharide and no difference in the amounts of the major OM porins (OmpA, OmpC, and OmpF) (see Fig. S2 in the supplemental material). Altogether, these data show that both PmrC- and CptA-mediated pEtN modifications are involved in maintaining OM integrity. Furthermore, they support the observation that the PmrC and CptA pEtN transferases are both required and act together in this process.

Fig. 4.

Fig. 4.

Absence of PmrAB-regulated pEtN transferases affects C. rodentium OM integrity. Cells were grown as described in Materials and Methods. Culture supernatant and periplasmic fractions from the various C. rodentium strains were assayed for β-lactamase activity using nitrocefin as a substrate. The cleavage of nitrocefin was monitored by measuring the absorbance at 482 nm over 30 min. The percentage of β-lactamase in the culture supernatant was calculated by determining the ratio of β-lactamase activity in the supernatant versus total β-lactamase activity in both fractions. For each strain, total β-lactamase activity was comparable. Values are means of data from three independent experiments ± standard deviations. **, Dunnett's test, P < 0.01 compared to wild-type measurements.

DISCUSSION

The PmrAB-regulated modifications that consist of the addition of 4-aminoarabinose (arn operon) and pEtN (pmrC and cptA) to LPS have been associated with PMB resistance and survival in excess iron in enterobacteria (14, 16, 34, 41). The arn operon, which is absent in C. rodentium, has been demonstrated to have a greater role in PMB resistance than the pEtN transferases encoded by pmrC and cptA (14, 34). Thus, the biological function of the pEtN transferases PmrC and CptA remains unclear. The fact that PmrC and CptA are required for maintaining OM integrity in C. rodentium is a novel finding. Several lines of evidence support this conclusion. First, the ΔpmrC, ΔpmrC ΔcptA, and ΔpmrAB strains had increased susceptibility to antibiotics that must cross the OM by diffusing through the LPS layer (lipophilic antibiotics and vancomycin). These increases in susceptibility were not observed for hydrophilic antibiotics that pass through porins. Second, permeability of the OM to two different fluorescent dyes (EtBr and NPN) was increased for all mutant strains, most notably for the ΔpmrC ΔcptA and ΔpmrAB strains. Third, β-lactamase release into culture supernatants revealed defects in OM integrity for the ΔpmrC ΔcptA and ΔpmrAB strains.

In MIC experiments, C. rodentium mutant strains showed hypersensitivity to ferrous (FeSO4) and ferric (FeCl3) iron compared to the wild-type strain (Table 3). Our results showed sensitivity to FeSO4 in the following order (from greatest to least sensitivity): the ΔpmrAB strain, the ΔpmrC ΔcptA strain, the ΔpmrC strain, the ΔcptA strain, and the wild type. Restoration of MIC values above the wild-type level was observed for the ΔpmrC-pWSKpmrC and ΔcptA-pWSKcptA complemented strains, confirming the involvement of both C. rodentium PmrC- and CptA-mediated pEtN modifications in resistance to excess iron. In contrast, neither PmrC nor CptA was found to promote C. rodentium resistance to PMB in N-minimal medium (Table 4). Consistently, complementation with pmrC, cptA, or pmrAB from a low-copy-number plasmid did not have an effect on PMB resistance under these conditions. However, the ΔpmrC, ΔpmrC ΔcptA, and ΔpmrAB strains showed a slight increase in susceptibility to PMB in LB (Table 4). These results are in agreement with those in previous studies that had shown a minor role for pEtN modifications in PMB resistance (14, 34).

Under PmrAB-inducing conditions, PmrC appeared to be more important than CptA in maintaining a robust OM permeability barrier. The ΔpmrC strain was consistently more susceptible than the wild type to both lipophilic antibiotics and vancomycin, whereas no change in MIC values was observed for the ΔcptA strain (Table 5). Although both the ΔpmrC and ΔcptA strains showed slight increases in OM permeability to EtBr and NPN compared to the wild-type strain, the ΔpmrC strain consistently exhibited a slightly higher influx of ethidium and accumulation of NPN compared to the ΔcptA strain (Fig. 2 and 3). The greater effect of PmrC than of CptA in contributing to the OM permeability barrier may be explained by differences in transcriptional regulation of the pmrC and cptA genes. β-Galactosidase reporter assays showed that pmrC and cptA expression was upregulated 45- and 2-fold, respectively, in the presence of 25 μM FeSO4 (Fig. 1C and D). Interestingly, the deletion of either pmrC or cptA did not affect OM integrity, as shown by the insignificant difference in the amounts of β-lactamase released from the periplasm compared to the wild type (Fig. 4). In contrast, the ΔpmrC ΔcptA strain exhibited more dramatic OM defects in all assays, including a large release of β-lactamase, indicative of a loss of OM integrity. These findings indicate that PmrC and CptA act together, possibly synergistically, to maintain the OM permeability barrier. This observation is supported by the fact that complementation of the ΔpmrC ΔcptA strain with either pWSKpmrC or pWSKcptA restored OM integrity, although subtle OM permeability defects were still observed (Fig. 3B and 4; Table 5). Essentially similar results were obtained for the ΔpmrAB and ΔpmrC ΔcptA strains, suggesting that no additional PmrAB-regulated gene is involved in maintaining C. rodentium OM integrity. Collectively, these data show that a lack of either pmrC or cptA leads to increased OM permeability, whereas a lack of both pEtN transferases grossly affects the OM, resulting in a loss of integrity.

In a previous study, Chamnongpol et al. observed that an S. enterica pmrA mutant had increased uptake of vancomycin under PhoPQ- and PmrAB-inducing conditions (5). This observation is in agreement with the finding that our C. rodentium ΔpmrAB strain is highly susceptible to lipophilic antibiotics and to vancomycin under similar growth conditions (Table 5). This may suggest that the OM strengthening attributed to pEtN transferases, observed in this study, is conserved among enterobacteria that possess the pmrC and cptA genes. This possibility could be tested by characterizing similar mutations in an S. enterica strain deficient in the arn operon. The loss of OM integrity that we observed for the ΔpmrC ΔcptA and ΔpmrAB strains has been reported for other gene mutations. For example, a mutation in the S. enterica waaP gene, encoding the kinase responsible for the phosphorylation of the core heptose I, resulted in an unstable OM as well as increased susceptibility to lipophilic antibiotics (42). Interestingly, both WaaP and CptA act on the same core sugar. A loss of OM integrity was also observed in mutants of the Tol-Pal complex, which serves as a structural link between the peptidoglycan layer and other cell wall components (4).

Finally, previous reports suggested the involvement of the S. enterica PmrAB TCS in producing a robust OM permeability barrier under Mg2+-limiting conditions (19, 25). Here, we have clearly shown the involvement of C. rodentium PmrAB in this process. In S. enterica, PmrAB is under the control of the PhoPQ TCS, which also regulates its own LPS-modifying genes (pagP, pagL, and lpxO). C. rodentium does not possess the pagL and lpxO homologues (28), the pmrD homologue, which bridges the PhoPQ and PmrAB signaling pathways, and a homologue to the arn operon. The lack of these homologues makes C. rodentium the appropriate model for studying the contribution of PmrAB-regulated pEtN transferases in strengthening the OM permeability barrier. The fact that pagP appears to be the sole C. rodentium LPS-modifying gene directly regulated by PhoPQ could explain the marginal contribution of this TCS to the production of a robust OM permeability barrier (Fig. 2B). The contribution of 4-aminoarabinose modifications in OM strengthening is still unclear. Kawasaki and Manabe showed that an S. enterica mutant of ugd (pmrE), a gene involved in the early steps of 4-aminoarabinose biosynthesis, displayed OM permeability defects similar to those of a pmrA mutant strain (19). This may suggest that modification of lipid A with 4-aminoarabinose also contributes to OM permeability in S. enterica. In conclusion, we have demonstrated that C. rodentium pmrC and cptA are the PmrAB-regulated genes responsible for maintaining a robust OM permeability barrier.

Supplementary Material

[Supplemental material]

ACKNOWLEDGMENTS

This work was supported by the Canadian Institutes of Health Research (CIHR) (MOP-15551) and the Natural Sciences and Engineering Research Council (NSERC) (217482). C.V. was supported by a studentship from the Fonds de la Recherche en Santé du Québec (FRSQ). D.K.T. was the recipient of an NSERC Undergraduate Student Research Award.

We thank J. L. Thomassin and J. Brannon for critical reading of the manuscript.

Footnotes

Supplemental material for this article may be found at http://jb.asm.org/.

Published ahead of print on 4 March 2011.

REFERENCES

  • 1. Aguirre A., Lejona S., Vescovi E. G., Soncini F. C. 2000. Phosphorylated PmrA interacts with the promoter region of ugd in Salmonella enterica serovar Typhimurium. J. Bacteriol. 182:3874–3876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Baümler A. J., et al. 1996. Identification of a new iron regulated locus of Salmonella typhi. Gene 183:207–213 [DOI] [PubMed] [Google Scholar]
  • 3. Bijlsma J. J., Groisman E. A. 2003. Making informed decisions: regulatory interactions between two-component systems. Trends Microbiol. 11:359–366 [DOI] [PubMed] [Google Scholar]
  • 4. Cascales E., Bernadac A., Gavioli M., Lazzaroni J. C., Lloubes R. 2002. Pal lipoprotein of Escherichia coli plays a major role in outer membrane integrity. J. Bacteriol. 184:754–759 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Chamnongpol S., Dodson W., Cromie M. J., Harris Z. L., Groisman E. A. 2002. Fe(III)-mediated cellular toxicity. Mol. Microbiol. 45:711–719 [DOI] [PubMed] [Google Scholar]
  • 6. Cullen T. W., Trent M. S. 2010. A link between the assembly of flagella and lipooligosaccharide of the Gram-negative bacterium Campylobacter jejuni. Proc. Natl. Acad. Sci. U. S. A. 107:5160–5165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Delcour A. H. 2009. Outer membrane permeability and antibiotic resistance. Biochim. Biophys. Acta 1794:808–816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Donnenberg M. S., Kaper J. B. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun. 59:4310–4317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Edwards R. A., Keller L. H., Schifferli D. M. 1998. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207:149–157 [DOI] [PubMed] [Google Scholar]
  • 10. Eguchi Y., Utsumi R. 2005. A novel mechanism for connecting bacterial two-component signal-transduction systems. Trends Biochem. Sci. 30:70–72 [DOI] [PubMed] [Google Scholar]
  • 11. Ernst R. K., Guina T., Miller S. I. 2001. Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 3:1327–1334 [DOI] [PubMed] [Google Scholar]
  • 12. Frirdich E., Whitfield C. 2005. Lipopolysaccharide inner core oligosaccharide structure and outer membrane stability in human pathogens belonging to the Enterobacteriaceae. J. Endotoxin Res. 11:133–144 [DOI] [PubMed] [Google Scholar]
  • 13. Gibbons H. S., Kalb S. R., Cotter R. J., Raetz C. R. 2005. Role of Mg2+ and pH in the modification of Salmonella lipid A after endocytosis by macrophage tumour cells. Mol. Microbiol. 55:425–440 [DOI] [PubMed] [Google Scholar]
  • 14. Groisman E. A., Kayser J., Soncini F. C. 1997. Regulation of polymyxin resistance and adaptation to low-Mg2+ environments. J. Bacteriol. 179:7040–7045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Gunn J. S. 2008. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol. 16:284–290 [DOI] [PubMed] [Google Scholar]
  • 16. Gunn J. S., et al. 1998. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 27:1171–1182 [DOI] [PubMed] [Google Scholar]
  • 17. Guo L., et al. 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250–253 [DOI] [PubMed] [Google Scholar]
  • 18. Kato A., Groisman E. A. 2004. Connecting two-component regulatory systems by a protein that protects a response regulator from dephosphorylation by its cognate sensor. Genes Dev. 18:2302–2313 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Kawasaki K., Manabe T. 2010. Latency of the lipid A deacylase PagL is involved in producing a robust permeation barrier in the outer membrane of Salmonella enterica. J. Bacteriol. 192:5837–5840 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Kox L. F., Wosten M. M., Groisman E. A. 2000. A small protein that mediates the activation of a two-component system by another two-component system. EMBO J. 19:1861–1872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Le Sage V., et al. 2009. An outer membrane protease of the omptin family prevents activation of the Citrobacter rodentium PhoPQ two-component system by antimicrobial peptides. Mol. Microbiol. 74:98–111 [DOI] [PubMed] [Google Scholar]
  • 22. Loh B., Grant C., Hancock R. E. 1984. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:546–551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Miller J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY [Google Scholar]
  • 24. Mortimer P. G., Piddock L. J. 1993. The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J. Antimicrob. Chemother. 32:195–213 [DOI] [PubMed] [Google Scholar]
  • 25. Murata T., Tseng W., Guina T., Miller S. I., Nikaido H. 2007. PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar Typhimurium. J. Bacteriol. 189:7213–7222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593–656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. 1972. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283–288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Petty N. K., et al. 2010. The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli. J. Bacteriol. 192:525–538 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Raetz C. R., Reynolds C. M., Trent M. S., Bishop R. E. 2007. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 76:295–329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Roland K., Curtiss R., III, Sizemore D. 1999. Construction and evaluation of a Δcya Δcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 43:429–441 [PubMed] [Google Scholar]
  • 31. Sambrook J., Fritsch E. F., Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY [Google Scholar]
  • 32. Schauer D. B., Falkow S. 1993. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect. Immun. 61:4654–4661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Soncini F. C., Groisman E. A. 1996. Two-component regulatory systems can interact to process multiple environmental signals. J. Bacteriol. 178:6796–6801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Tamayo R., et al. 2005. Identification of cptA, a PmrA-regulated locus required for phosphoethanolamine modification of the Salmonella enterica serovar Typhimurium lipopolysaccharide core. J. Bacteriol. 187:3391–3399 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Tamayo R., Prouty A. M., Gunn J. S. 2005. Identification and functional analysis of Salmonella enterica serovar Typhimurium PmrA-regulated genes. FEMS Immunol. Med. Microbiol. 43:249–258 [DOI] [PubMed] [Google Scholar]
  • 36. Vaara M., Vaara T. 1981. Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob. Agents Chemother. 19:578–583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Vaara M., Vaara T., Sarvas M. 1979. Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium. J. Bacteriol. 139:664–667 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Wang R. F., Kushner S. R. 1991. Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100:195–199 [PubMed] [Google Scholar]
  • 39. Wiegand I., Hilpert K., Hancock R. E. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3:163–175 [DOI] [PubMed] [Google Scholar]
  • 40. Winfield M. D., Latifi T., Groisman E. A. 2005. Transcriptional regulation of the 4-amino-4-deoxy-L-arabinose biosynthetic genes in Yersinia pestis. J. Biol. Chem. 280:14765–14772 [DOI] [PubMed] [Google Scholar]
  • 41. Wosten M. M., Kox L. F., Chamnongpol S., Soncini F. C., Groisman E. A. 2000. A signal transduction system that responds to extracellular iron. Cell 103:113–125 [DOI] [PubMed] [Google Scholar]
  • 42. Yethon J. A., et al. 2000. Salmonella enterica serovar Typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence in vivo. Infect. Immun. 68:4485–4491 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Zhou Z., et al. 2001. Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PmrA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation. J. Biol. Chem. 276:43111–43121 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Supplemental material]
supp_193_9_2168__1.pdf (409.2KB, pdf)

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES